Industry News
Potential Target Identified For Reducing The Progression Of Metastases, The Main Cause Of Death For Breast Cancer Patients
Apr 18, 2013
A team of researchers at the IRCM, led by Dr. Jean-Francois Cote, made an important discovery in breast cancer, which is publisheded online this week by the scientific journal Proceedings of the National Academy of Sciences (PNAS)... Read More
The Effectiveness Of Breast Cancer Treatment Could Be Improved By Nanodiamonds
Apr 18, 2013
Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment... Read More
Study Examines Downstream Outcomes Following Prostate-Specific Antigen Screening In Older Men
Apr 17, 2013
A study by Louise C. Walter, M.D., of San Francisco Veterans Affairs Medical Center, California, and colleagues sought to quantify 5-year downstream outcomes following an abnormal prostate-specific antigen (PSA) screening result of 4.0 ng/mL or more, in older men... Read More
Protein Helps Leukemia Cells Avoid Effects Of Chemotherapy By Appearing Dormant
Apr 17, 2013
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer... Read More
News From Annals Of Internal Medicine: 16 April 2013
Apr 17, 2013
1. Task Force Reviews Evidence for New Recommendations on Medications to Reduce Risk for Primary Breast Cancer High-risk women may derive the most benefit, least harms from preventive drug therapy Women at high risk for breast cancer may benefit most from preventive drug therapy... Read More
PSA Screening May Be Personalized To Improve Specificity, Reduce Biopsies
Apr 17, 2013
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology® reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others... Read More
Prostatic Artery Embolization, A Nonsurgical Treatment Turns Back The Clock, Shrinks Enlarged Prostate
Apr 17, 2013
Men with a common condition that causes frequent nighttime trips to the bathroom can get relief with a minimally invasive treatment that shrinks the prostate, suggests a study presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. The early findings hail from the first prospective U.S... Read More
Gene Identified That Mediates Cisplatin Resistance In Ovarian Cancer
Apr 17, 2013
Platinum compounds, such as cisplatin and carboplatin, induce DNA cross-linking, prohibiting DNA synthesis and repair in rapidly dividing cells. They are first line therapeutics in the treatment of many solid tumors, but cancer cells frequently develop resistance to these drugs. Mechanisms of resistance typically include reduced platinum uptake and increased platinum export... Read More
Advanced Cancers That Have Spread To The Lungs Can Be Treated Using Cryoablation
Apr 17, 2013
Frozen balls of ice can safely kill cancerous tumors that have spread to the lungs, according to the first prospective multicenter trial of cryoablation. The results were presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans... Read More
Study Assesses Outcomes Of Prostate-Specific Antigen Screening Among Older Men
Apr 17, 2013
A new study has examined the outcomes of an abnormal prostate-specific antigen (PSA) screening result of 4.0 ng/mL or more among men over the age of 65. The study, led by Louise C. Walter, M.D., of San Francisco Veterans Affairs Medical Center, included a total of 295,645 men 65 years or older who underwent PSA screening in 2003. The participants were followed up for a total of five years... Read More
Previous Page Next Page